Pharma lobby obtains stay on Centre’s drug price control order
Drug manufacturers also trying to scuttle government’s drug pricing policy
Gopal Subramaniam, Rohinton Nariman swap places in Novartis patent case
Will take on each other in the patent case of anti-cancer drug Glivec filed by Novartis
Clinical trials: illogical compensation formula
Health ministry finally drafts formula to compensate victims of drug trials. Experts wary; say formula is shoddy and ill-conceived
Health activists ask Centre to stand firm on price control order for 50 life-saving drugs
Contrary to pharma industry claims, price control notifications for 50 cardiovascular and anti-diabetic drugs will impact retail market only …
Substantiate allegations against Ranbaxy, says Supreme Court
Experts say allegations against the generic pharma company motivated by vested interests